Estradiol Valerate: Properties, Uses & Research Guide
Estradiol Valerate: Properties, Uses & Research Guide
Estradiol valerate is a synthetic ester prodrug of 17β-estradiol widely employed in endocrinology research as a long-acting estrogenic compound for in vitro and in vivo experimental models.
- Chemical Name
- Estradiol 17-valerate (17β-estradiol 17-pentanoate)
- SKU / Catalog Number
- E409246 (Selleck reference: S3149)
- Compound Class
- Synthetic steroidal estrogen; ester prodrug
- Primary Target
- Estrogen receptors ERα and ERβ (active after hydrolysis to estradiol)
- Research Application
- Hormone replacement models, reproductive biology, oncology, neuroscience
- Solubility
- Soluble in ethanol and DMSO; poorly soluble in aqueous buffers
Chemical Identity and Physical Properties
Estradiol valerate (E409246) is the C-17 valeric acid ester of 17β-estradiol, the primary endogenous estrogen in mammals. Esterification at the 17β-hydroxyl group renders the molecule more lipophilic than the parent hormone, improving stability and modifying its release profile in biological systems. The compound is a white to off-white crystalline powder with a steroidal backbone characteristic of estrogen hormones.
Key physicochemical attributes include enhanced lipophilicity relative to free estradiol, poor aqueous solubility, and good solubility in organic solvents such as absolute ethanol and dimethyl sulfoxide (DMSO). Researchers are advised to prepare stock solutions in DMSO or ethanol and dilute into aqueous media immediately before use to minimize precipitation. Storage under inert atmosphere at low temperature is recommended to prevent oxidative degradation of the steroid nucleus.
Mechanism of Action
Estradiol valerate functions as a prodrug. Following administration or addition to biological systems, esterases cleave the valerate moiety to release free 17β-estradiol. The liberated estradiol then binds with high affinity to estrogen receptors ERα (ESR1) and ERβ (ESR2), which are ligand-activated transcription factors belonging to the nuclear receptor superfamily.
Ligand-bound estrogen receptors dimerize, translocate to the nucleus, and bind estrogen response elements (EREs) in the promoter regions of target genes, modulating transcription of genes involved in cell proliferation, differentiation, metabolism, and neuroprotection. In addition to this classical genomic pathway, estradiol can activate rapid non-genomic signaling cascades including MAPK, PI3K/Akt, and cAMP pathways through membrane-associated receptors. The ester prodrug design allows researchers to study sustained estrogenic signaling in cell culture and animal models without repeated dosing of the labile parent hormone.
Research Applications
Reproductive Biology and Endocrinology: Estradiol valerate is extensively used to model estrogen-deficient or estrogen-replete states in ovariectomized rodent models, enabling study of the hypothalamic-pituitary-gonadal axis, bone metabolism, and metabolic syndrome. It serves as a standard positive control for estrogenic activity assays.
Oncology Research: Because many breast and endometrial cancers are estrogen-sensitive, estradiol valerate is employed to stimulate estrogen receptor-positive (ER+) tumor cell lines (e.g., MCF-7) and to evaluate the efficacy of antiestrogens, selective estrogen receptor modulators (SERMs), and aromatase inhibitors in preclinical models.
Neuroscience: Estrogen exerts neuroprotective effects and modulates cognition, mood, and neuroinflammation. Researchers use estradiol valerate to investigate estrogen's role in Alzheimer's disease models, stroke recovery, and serotonergic/dopaminergic system regulation.
Transgender Medicine and Gender-Affirming Research: As a clinically relevant form of estrogen, estradiol valerate is used in translational research modeling feminizing hormone therapy, providing a pharmacologically relevant experimental system.
Laboratory Handling, Storage, and Safety
Stock Solution Preparation: Dissolve estradiol valerate in DMSO or absolute ethanol to prepare a concentrated stock solution (typically 10–100 mM). Verify complete dissolution before further dilution. When diluting into aqueous media, use warm solution and vortex thoroughly; final DMSO concentrations in cell culture should generally not exceed 0.1% (v/v) to avoid vehicle cytotoxicity.
Storage: Store the solid compound at −20 °C under desiccating conditions and protected from light. Aliquot stock solutions to avoid repeated freeze-thaw cycles. Under recommended storage conditions, the compound is expected to remain stable for at least two years; however, researchers should verify activity by assay if material has been stored for extended periods.
Safety Considerations: Estradiol valerate is a potent estrogenic compound. Handle with appropriate personal protective equipment including gloves and laboratory coat. Avoid inhalation of dust or aerosols. As an endocrine-active substance, minimize exposure and dispose of according to local institutional and regulatory guidelines for hormonal compounds. Consult the Safety Data Sheet (SDS) provided by Aladdin Scientific before use.
Frequently asked questions
What is the difference between estradiol valerate and estradiol?
Estradiol valerate is an ester prodrug of 17β-estradiol formed by esterification of the C-17 hydroxyl group with valeric acid. It is biologically inactive until esterases cleave the valerate group to release free 17β-estradiol. The esterification increases lipophilicity and prolongs the effective duration of estrogenic activity compared to unmodified estradiol.
Which solvents are recommended for dissolving estradiol valerate in the laboratory?
Estradiol valerate is best dissolved in DMSO or absolute ethanol to prepare stock solutions. It has poor solubility in aqueous buffers and water. For cell-based assays, stock solutions should be diluted into the aqueous medium immediately before use, and the final vehicle concentration should be kept as low as possible (typically ≤0.1% DMSO) to avoid confounding cytotoxic effects.
What in vitro cell models are commonly used with estradiol valerate?
The most widely used cell lines with estradiol valerate include MCF-7 (ER+ breast cancer), T47D (ER+ breast cancer), Ishikawa (endometrial), and primary neuronal cultures for neuroprotection studies. These lines express functional estrogen receptors and respond robustly to estrogenic stimulation, making them suitable for evaluating estrogenic activity and testing anti-estrogenic compounds.
How should estradiol valerate be stored to ensure long-term stability?
Store the solid compound at −20 °C in a sealed, desiccated container protected from light and moisture. Aliquot dissolved stock solutions into single-use volumes to avoid freeze-thaw degradation. If stored under these conditions, the compound is generally expected to remain stable for at least two years, though periodic activity verification is recommended for critical experiments.
References
- Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005;8(Suppl 1):3–63. doi:10.1080/13697130500148875
- Nilsson S, Gustafsson JÅ. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther. 2011;89(1):44–55. doi:10.1038/clpt.2010.226
- Selleck Chemicals. Estradiol valerate (S3149) product information. Selleck Chemicals LLC.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)